Does Enliven Therapeutics, Inc. (ELVN) Have the Potential to Rally 87.49% as Wall Street Analysts Expect?

Core Viewpoint - Enliven Therapeutics, Inc. (ELVN) shows significant upside potential, with a mean price target of $41.38 indicating an 87.5% increase from the current trading price of $22.07 [1] Price Targets - The average of eight short-term price targets ranges from a low of $33.00 to a high of $52.00, with a standard deviation of $6.52, suggesting a variability in analyst estimates [2] - The lowest estimate indicates a potential increase of 49.5%, while the highest suggests a 135.6% upside [2] Analyst Consensus and Earnings Estimates - Analysts are optimistic about ELVN's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which has shown a strong correlation with stock price movements [4][11] - The Zacks Consensus Estimate for the current year has increased by 4.1% over the past month, with one estimate rising and no negative revisions [12] Zacks Rank - ELVN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for near-term upside [13] Price Movement Guidance - While consensus price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [14]